Track SVRA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Savara Inc
The Tannery, Yardley, PA, United States, 19067
IPO
2017
Employees
70
Industry
Biotechnology
Sector
Healthcare
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q2 20250+2
2
Analyst Ratings
4 analysts covering
Buy50%recommend buy
Buy
2
Hold
2
Sell
0